HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting a Designer TIMP-1 to the Cell Surface for Effective MT1-MMP Inhibition: A Potential Role for the Prion Protein in Renal Carcinoma Therapy.

Abstract
Renal carcinoma cells express Membrane Type 1-Matrix Metalloproteinase (MT1-MMP, MMP-14) to degrade extracellular matrix components and a range of bioactive molecules to allow metastasis and cell proliferation. The activity of MT1-MMP is modulated by the endogenous inhibitors, Tissue Inhibitor of Metalloproteinases (TIMPs). In this study, we describe a novel strategy that would enable a "designer" TIMP-1 tailored specifically for MT1-MMP inhibition (V4A/P6V/T98L; Kiapp 1.66 nM) to be targeted to the plasma membrane for more effective MT1-MMP inhibition. To achieve this, we fuse the designer TIMP-1 to the glycosyl-phosphatidyl inositol (GPI) anchor of the prion protein to create a membrane-tethered, high-affinity TIMP variant named "T1Pr αMT1" that is predominantly located on the cell surface and co-localised with MT1-MMP. Confocal microscopy shows that T1Pr αMT1 is found throughout the cell surface in particular the membrane ruffles where MT1-MMP is most abundant. Expression of T1Pr αMT1 brings about a complete abrogation of the gelatinolytic activity of cellular MT1-MMP in HT1080 fibrosarcoma cells whilst in renal carcinoma cells CaKi-1, the GPI-TIMP causes a disruption in MMP-mediated proteolysis of ECM components such as fibronectin, collagen I and laminin that consequently triggers a downstream senescence response. Moreover, the transduced cells also suffer from an impairment in proliferation and survival in vitro as well as in NOD/SCID mouse xenograft. Taken together, our findings demonstrate that the GPI anchor of prion could be exploited as a targeting device in TIMP engineering for MT1-MMP inhibition with a potential in renal carcinoma therapy.
AuthorsBingjie Jiang, Jian Liu, Meng Huee Lee
JournalMolecules (Basel, Switzerland) (Molecules) Vol. 24 Issue 2 (Jan 11 2019) ISSN: 1420-3049 [Electronic] Switzerland
PMID30641935 (Publication Type: Journal Article)
Chemical References
  • Matrix Metalloproteinase Inhibitors
  • Prion Proteins
  • Tissue Inhibitor of Metalloproteinase-1
  • Matrix Metalloproteinase 14
Topics
  • Animals
  • Carcinoma, Renal Cell (drug therapy, genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Membrane (metabolism)
  • Cellular Senescence
  • Disease Models, Animal
  • Gene Expression
  • Humans
  • Matrix Metalloproteinase 14 (chemistry, genetics, metabolism)
  • Matrix Metalloproteinase Inhibitors (chemistry, pharmacology)
  • Mice
  • Prion Proteins (antagonists & inhibitors)
  • Tissue Inhibitor of Metalloproteinase-1 (antagonists & inhibitors, chemistry, metabolism)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: